79 results
8-K
EX-10.1
SMTI
Sanara MedTech Inc
18 Apr 24
Sanara MedTech Inc. Announces $55 Million Debt Facility
9:20am
from the taxable income of such Obligor, which, for the avoidance of doubt, shall take into account (i) losses available to offset such taxable income
8-K
EX-10.1
SMTI
Sanara MedTech Inc
5 Apr 24
Departure of Directors or Certain Officers
9:15am
under this Agreement shall be subject to offset to the extent permitted by law by the amount of actual damages, if any, caused to either Party by any
8-K
EX-99.1
SMTI
Sanara MedTech Inc
25 Mar 24
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
4:37pm
, partially offset by higher SG&A costs, higher R&D expenses, and higher amortization of our acquired intangible assets. For the year ended December
8-K
EX-2.1
ni35 dol5mr8770owq
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-10.2
klhzhpocu254zbb 8919
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-2.1
wumu7h do
5 Jul 22
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
9:20am
DEFA14A
1d5fe84tmuooa4ibwgd
29 Apr 22
Additional proxy soliciting materials
8:35am
8-K
EX-10.1
578br q61buq450k93
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-10.2
zgc53b zjtoc
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-10.3
601nrlz
8 Apr 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-2.1
c548usu w64
4 Apr 22
Entry into a Material Definitive Agreement
6:34am
8-K
EX-99.1
lel9y
15 Nov 21
Sanara MedTech Inc. Announces Third Quarter 2021 Results and Business Update
12:00am